The FY24 TERP CTA is intended to support the rapid implementation of clinical trials with the potential to have a significant impact on the prevention, treatment or management of symptoms, diseases, or conditions associated with or resulting from military-related toxic exposures. To meet the intent of the award mechanism, applications must address at least one of the FY24 TERP Program Goals and at least one of the FY24 TERP Topic Areas.